glp-1 compounding crackdown news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our I'm stuck in the gray

Since then, drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have gained wide attention for their effectiveness in weight loss

Since its discovery in 1984 by Svetlana Mosjov, GLP-1 and its analogs (such as semaglutide, liraglutide, and dulaglutide) have rapidly become cornerstone treatments for type 2 diabetes mellitus (T2DM) and obesity

Pennsylvania Medicaid stopped covering GLP-1s for obesity this year, but it's not all savings The cost of GLP-1s for Pa

Pyzchiva will be commercialized in the U.S

An interesting question is whether one of these hormones contributes more to tirzepatides effects than the other

Smoking cessation and weight gain